kaonavi
4435
Itamiarts
168A
D. Western Therapeutics Institute
4576
Allied Telesis Holdings KK
6835
Wintest
6721
(Q3)Dec 31, 2024 | (Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q4)Mar 31, 2023 | (Q3)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 4.43%18.92B | 15.83%19.44B | -0.07%74.6B | -0.30%21.65B | 1.25%18.12B | 1.47%18.05B | -2.73%16.79B | 7.71%74.66B | 6.47%21.71B | 7.68%17.9B |
Cost of revenue | 1.50%7.29B | 15.91%8.04B | -2.90%31.64B | -1.33%9.4B | -2.60%7.18B | -1.91%8.13B | -6.33%6.94B | 7.74%32.59B | 4.43%9.53B | 5.60%7.37B |
Gross profit | 6.35%11.63B | 15.78%11.4B | 2.13%42.96B | 0.50%12.25B | 3.94%10.94B | 4.43%9.93B | -0.03%9.85B | 7.68%42.07B | 8.13%12.19B | 9.18%10.52B |
Operating expense | 6.04%10.16B | 5.99%9.48B | 4.41%37.7B | 3.36%10.19B | 3.13%9.58B | 6.12%8.99B | 5.32%8.95B | 3.47%36.11B | 4.32%9.86B | 6.92%9.29B |
Operating profit | 8.47%1.47B | 112.86%1.92B | -11.72%5.26B | -11.59%2.06B | 10.06%1.36B | -9.36%939M | -33.53%902M | 42.98%5.96B | 27.90%2.33B | 29.93%1.23B |
Net non-operating interest income (expenses) | -7.14%26M | 108.33%50M | 23.14%149M | 40.48%59M | 16.67%28M | 80.95%38M | -29.41%24M | 120.00%121M | 147.06%42M | 200.00%24M |
Non-operating interest income | 38.71%43M | 96.15%51M | 8.97%158M | 29.79%61M | 6.90%31M | 60.00%40M | -40.91%26M | 59.34%145M | 95.83%47M | 70.59%29M |
Non-operating interest expense | 466.67%17M | -50.00%1M | -62.50%9M | -60.00%2M | -40.00%3M | -50.00%2M | -80.00%2M | -33.33%24M | -28.57%5M | -44.44%5M |
Net investment income | 607.32%416M | 71.58%477M | 1,996.55%550M | 759.38%275M | 38.35%-82M | 154.11%79M | 27.52%278M | -110.55%-29M | -76.12%32M | -243.01%-133M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | ||||||||||
Income from associates and other participating interests | ||||||||||
Special income (charges) | -5,488.89%-503M | -101.17%-5M | 257.58%472M | -17.65%56M | -350.00%-9M | -105.97%-4M | 43,000.00%429M | 123.73%132M | -20.00%68M | 66.67%-2M |
Less:Other special charges | -22.22%7M | 66.67%5M | 69.70%-40M | 17.65%-56M | 350.00%9M | 105.97%4M | 200.00%3M | -123.73%-132M | 20.00%-68M | -66.67%2M |
Less:Write off | --0 | --0 | ---432M | --0 | --0 | --0 | ---432M | --0 | --0 | --0 |
Other non-operating income (expenses) | -29.41%36M | -16.13%52M | 52.00%266M | 327.59%124M | -7.27%51M | -14.71%29M | 8.77%62M | 6.06%175M | -12.12%29M | 37.50%55M |
Income before tax | 7.12%1.45B | 47.08%2.49B | 5.35%6.7B | 2.80%2.57B | 14.71%1.35B | 6.72%1.08B | 1.74%1.7B | 34.70%6.36B | 19.72%2.5B | 8.39%1.18B |
Income tax | 40.16%527M | 16.23%752M | 7.69%1.86B | -18.26%582M | 9.94%376M | 37.23%258M | 32.58%647M | 51.75%1.73B | 23.83%712M | 4.27%342M |
Net income | -5.66%917M | 66.03%1.74B | 4.48%4.83B | 11.24%1.99B | 16.41%972M | -0.24%822M | -10.96%1.05B | 29.23%4.62B | 18.02%1.79B | 10.45%835M |
Net income continuous operations | -5.65%918M | 66.13%1.74B | 4.48%4.83B | 11.18%1.99B | 16.67%973M | -0.24%822M | -11.04%1.05B | 29.26%4.63B | 18.16%1.79B | 10.17%834M |
Noncontrolling interests | ||||||||||
Net income attributable to the company | -5.66%917M | 66.03%1.74B | 4.48%4.83B | 11.24%1.99B | 16.41%972M | -0.24%822M | -10.96%1.05B | 29.23%4.62B | 18.02%1.79B | 10.45%835M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | -5.66%917M | 66.03%1.74B | 4.48%4.83B | 11.24%1.99B | 16.41%972M | -0.24%822M | -10.96%1.05B | 29.23%4.62B | 18.02%1.79B | 10.45%835M |
Gross dividend payment | ||||||||||
Basic earnings per share | -3.68%14.12 | 69.12%26.535 | 5.63%72.74 | 12.71%30.06 | 17.70%14.66 | 0.53%12.33 | -10.19%15.69 | 30.94%68.86 | 19.38%26.67 | 11.35%12.455 |
Diluted earnings per share | -3.68%14.12 | 69.12%26.535 | 5.63%72.74 | 12.71%30.06 | 17.72%14.66 | 0.53%12.33 | -10.19%15.69 | 30.94%68.86 | 19.38%26.67 | 11.34%12.4535 |
Dividend per share | 0 | 0 | -16.67%50 | -16.67%50 | 0 | 0 | 0 | 100.00%60 | 100.00%60 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |